Nurix Therapeutics, Inc.
USD24.20
+0.35 (+1.49%)
CEO
Arthur T. Sands
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$23.94
Prev. Close
$23.85
Day Low
$23.52
Day High
$24.72
52W Low
$8.20
52W High
$24.72
Market Cap
$2.10B
Volume
0.63M
| -7.7 |
| 30 Nov 2023 | FY | -145.7% | -187.0% | -71.8% | -40.5% | 0.15 | 3.40 | -2.3 |
| 30 Nov 2022 | FY | -377.6% | -466.9% | -59.4% | -43.3% | 0.04 | 4.51 | -3.3 |
| 30 Nov 2021 | FY | -291.4% | -393.9% | -34.2% | -24.6% | 0.04 | 4.70 | -10.5 |
| 30 Nov 2020 | FY | -273.1% | -242.7% | -14.9% | -10.9% | 0.00 | 6.70 | -15.4 |
| 30 Nov 2019 | FY | -44.7% | -69.7% | 37.6% | -49.3% | 0.00 | 2.44 | -34.0 |
| 30 Nov 2018 | FY | -8.2% | -25.2% | 25.6% | -20.8% | 0.00 | 1.24 | -32.5 |
| -5.1 |
| 31 Aug 2025 | Q3 | 36.7% | -1094.8% | -23.2% | -16.5% | 0.15 | 5.35 | -2.3 |
| 31 May 2025 | Q2 | -77.3% | -98.7% | -9.7% | -7.3% | 0.12 | 6.82 | -5.1 |
| 28 Feb 2025 | Q1 | -277.5% | -305.4% | -11.7% | -9.2% | 0.06 | 6.26 | -5.7 |
| 30 Nov 2024 | Q4 | -406.1% | -440.7% | -11.1% | -8.7% | 0.05 | 6.46 | -7.4 |
| 31 Aug 2024 | Q3 | -340.7% | -388.9% | -13.0% | -9.5% | 0.07 | 5.28 | -9.4 |
| 31 May 2024 | Q2 | -304.6% | -368.4% | -12.0% | -8.7% | 0.08 | 5.57 | -5.5 |
| 29 Feb 2024 | Q1 | -201.5% | -250.3% | -24.6% | -13.3% | 0.17 | 2.86 | -4.1 |
| 30 Nov 2023 | Q4 | -227.9% | -276.8% | -20.9% | -11.8% | 0.15 | 3.40 | -2.0 |